Genpact stock: buy or sell?
February 14th, 2020
Genpact Limited provides business process outsourcing and information technology (IT) management services worldwide. The company offers finance and accounting services, including accounts payable comprising document management, invoice processing, approval, resolution management, and T&E processing; order to cash services, such as customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services consisting of accounting, closing and reporting, treasury, tax, and product cost accounting services; enterprise performance management, including budgeting, forecasting, business performance reporting, and analytics; and enterprise risk and compliance services comprising SOX advisory, enterprise risk management, internal audit, FCPA, and IT risk management services.
Should I buy Genpact stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Genpact stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Genpact stock a buy?
Financial institutions and banks publish stock ratings everyday.Unfortunately, we couldn't find any rating for G stock for the last 30 days.
Genpact stock analysis
Genpact inched 0.57% to $43.77 after topping to all time highs on Feb/6.
Genpact inched 0.57% on February/14 to $43.77 after marking all time highs on February 6th. Since SMA50d and SMA100d crossed up on December, G price climbed $2.22 per share (5.34%). Since last October when G stock price broke up the SMA100d line, it gained $5.04 (13.01%). On February 6th, G hit a new all time high, pushing higher than on February 4th tops. Check different trading setups that use ATHs as triggers.
Genpact shares jumped 2.82% this week, ending at $43.77.
Genpact stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Not so far away is the last price record Genpact marked last week. Since SMA20d and SMA40w crossed up by mid March 2019, G price climbed $10.56 per share (31.80%). Since price and SMA20w lines crossed up by mid November 2019, G climbed $4.49 (11.43%).
Genpact stock price history
Genpact IPO was on August 2nd, 2007 at $11.96 per share1. Since then, G stock surged a 266.00%, with an average of 22.20% per year. If you had invested right after G's IPO a $1,000 in Genpact stock in 2007, it would worth $2,660.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Genpact stock historical price chart
G stock reached all-time highs on February 6th with a price of $45.20.
Genpact stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price forecast for Genpact stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareSince last May, when Genpact presented its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw a great increase of 9.64% to $3,000.79 million USD. When comparing 2018 vs 2017, nonetheless, profit margin (that is, the net income divided by revenues) remained constant a -0.16% to 9.37%. To have an updated view of the financial situation of Genpact, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Genpact TTM sales up to March 2019 were $3,121.08 and earnings were $278.17 million USD. When comparing this TTM figures with the last reported annuality, we can review Genpact business evolution since December 2018: Annual revenues up to March, compared to lastest yearly report, grew a beatiful 4.01%. Regarding profit margin, Genpact stayed stable -0.46% to 9.37%
|2013||$2,120 M||-||$230 M10.8%||-|
|2014||$2,279 M||7.52%||$192 M8.4%||-16.42%|
|2015||$2,461 M||7.97%||$240 M9.7%||24.90%|
|2016||$2,571 M||4.46%||$268 M10.4%||11.56%|
|2017||$2,737 M||6.46%||$261 M9.5%||-2.51%|
|2018||$3,001 M||9.64%||$281 M9.4%||7.83%|
|TTM||$3,121 M||4.01%||$278 M8.9%||-1.10%|
Quarterly financial resultsGenpact posted $809.21 million in sales for 2019-Q1, a -3.13% less compared to previous quarter. Reported quarter earnings marked $60.84 million with a profit margin of 7.52%. Profit margin decreased a -1.96% compared to previous quarter when profit margin was 9.47%. When comparing turnover to same quarter last year, Genpact sales marked a super good growth and skyrocketed a 17.46%.
|2017-Q2||$668 M||-||$69 M10.3%||-|
|2017-Q3||$709 M||6.04%||$74 M10.4%||6.95%|
|2017-Q4||$734 M||3.61%||$67 M9.1%||-9.04%|
|2018-Q1||$689 M||-6.20%||$65 M9.4%||-3.56%|
|2018-Q2||$729 M||5.76%||$65 M8.9%||-0.19%|
|2018-Q3||$748 M||2.67%||$74 M9.8%||13.98%|
|2018-Q4||$835 M||11.68%||$79 M9.5%||7.53%|
|2019-Q1||$809 M||-3.13%||$61 M7.5%||-23.13%|
Genpact ownershipWhen you are planning to buy a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Genpact, 100.01% of all outstanding shares are owned by its staff.
In case of Genpact stock, 57.13% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for G stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related companies:
|Market cap||$8.3 B|
|Total shares||190.0 M|
|Float shares||177.6 M|
|- Institutional holdings (%)||57.1%|
|- Insider holdings (%)||100.0%|
|Shares in short selling||0.0%|
|Friday, February 14th, 2020|
|Day range||$43.34 - $43.77|
|Average true range||$0.84|
|50d mov avg||$42.89|
|100d mov avg||$41.03|
|200d mov avg||$39.65|
Genpact performanceTo better understand Genpact performance you must becnhmark its gains with other related stocks in same sector or industry. We compared Genpact against in the following table:
Genpact competitorsUnfortunately, we could not find any public company that could be defined as Genpact competitor. This doesn't mean Genpact does not have any competitor in the market, it's just we could not detected it.
Latest Genpact stock news
- Seeking AlphaGenpact Limited: A Buy At These LevelsJune 26, 2018